Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Watchlist Manager
Avadel Pharmaceuticals PLC Logo
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Watchlist
Price: 15.49 USD -2.82% Market Closed
Updated: May 20, 2024

Avadel Pharmaceuticals PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avadel Pharmaceuticals PLC
Operating Income Peer Comparison

Comparables:
PRGO
JAZZ
G
GHRS
COPN
OVB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Income
-$148.7m
CAGR 3-Years
-45%
CAGR 5-Years
-36%
CAGR 10-Years
-9%
Perrigo Company PLC
NYSE:PRGO
Operating Income
$221.1m
CAGR 3-Years
-4%
CAGR 5-Years
-13%
CAGR 10-Years
-10%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Income
$518.7m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
10%
G
GH Research PLC
NASDAQ:GHRS
Operating Income
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Income
€12.2m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Ovoca Bio PLC
LSE:OVB
Operating Income
-€2.3m
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
12%

See Also

What is Avadel Pharmaceuticals PLC's Operating Income?
Operating Income
-148.7m USD

Based on the financial report for Mar 31, 2024, Avadel Pharmaceuticals PLC's Operating Income amounts to -148.7m USD.

What is Avadel Pharmaceuticals PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-9%

Over the last year, the Operating Income growth was -51%. The average annual Operating Income growth rates for Avadel Pharmaceuticals PLC have been -45% over the past three years , -36% over the past five years , and -9% over the past ten years .